StockData
NeOnc Technologies Holdings, Inc. logo

NeOnc Technologies Holdings, Inc. (NTHI) stock

NTHINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 0/30
$4.16−0.17 (-3.93%)

Close on Nov 18, 2026Market cap $107.89MP/E –Yield –

NeOnc Technologies r&d expenses

Research and development expenses are spending on new products and technology.

NeOnc Technologies's R&D Expenses for the twelve months ending Sep 30, 2026 was $6.53M, up 88.2% year over year. For fiscal 2025 it was $3.64M, up 19.5% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.64M+19.5%
FY2024Dec 31, 2024$3.05M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.31M+82.9%
Q2 FY2026Jun 30, 2026$2.65M+291.2%
Q1 FY2026Mar 31, 2026$1.29M+28.9%
Q4 FY2025Dec 31, 2025$1.29M+19.3%
Q3 FY2025Sep 30, 2025$715.04K-25.3%
Q2 FY2025Jun 30, 2025$677.33K+71.7%
Q1 FY2025Mar 31, 2025$998.22K+62.4%
Q4 FY2024Dec 31, 2024$1.08M–
Q3 FY2024Sep 30, 2024$956.73K–
Q2 FY2024Jun 30, 2024$394.48K–
Q1 FY2024Mar 31, 2024$614.52K–

More NeOnc Technologies figures

See a number that looks wrong?